Renvela® (sevelamer) – Expanded indication
November 25, 2016 – The FDA approved Genzyme’s Renvela (sevelamer) tablets and oral suspension, for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.
Download PDF
